Evidence map›Paper›PMID 27446426›Full record

ArticleOncology letters2016

SIX1 coordinates with TGFβ signals to induce epithelial-mesenchymal transition in cervical cancer.

Shu-Hua Sun, Dan Liu, Yun-Te Deng, Xiao-Xue Zhang, Dong-Yi Wan, Bi-Xin Xi, Wei Huang, Qian Chen, Meng-Chen Li, Ming-Wei Wang and 4 more

Open access · diamondAbstract read
In one paragraph

Article in Oncology letters, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Shu-Hua SunDepartment of Gynecologic Oncology, Hubei Cancer Hospital, Wuhan, Hubei 430023, P.R. China.
Dan LiuCancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430074, P.R. China.
Yun-Te DengDepartment of Pathology, Hubei Cancer Hospital, Wuhan, Hubei 430023, P.R. China.
Xiao-Xue ZhangCancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430074, P.R. China.
Dong-Yi WanCancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430074, P.R. China.
Bi-Xin XiCancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430074, P.R. China.
Wei HuangDepartment of Gynecologic Oncology, Hubei Cancer Hospital, Wuhan, Hubei 430023, P.R. China.
Qian ChenDepartment of Gynecologic Oncology, Hubei Cancer Hospital, Wuhan, Hubei 430023, P.R. China.
Meng-Chen LiCancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430074, P.R. China.
Ming-Wei WangDepartment of Pathology, Hubei Cancer Hospital, Wuhan, Hubei 430023, P.R. China.
Fei YangDepartment of Pathology, Hubei Cancer Hospital, Wuhan, Hubei 430023, P.R. China.
Ping ShuDepartment of Medical Records Room, Hubei Cancer Hospital, Wuhan, Hubei 430023, P.R. China.
Ke-Zhi WuDepartment of Medical Records Room, Hubei Cancer Hospital, Wuhan, Hubei 430023, P.R. China.
Qing-Lei GaoCancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430074, P.R. China.
Hubei Cancer Hospital · CNTongji Hospital · CNHuazhong University of Science and Technology · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Epithelial-mesenchymal transition (EMT) plays a critical role in promoting tumor invasion and metastasis. However, the key cofactors that modulate the signal transduction to induce EMT have note been fully explored to date. The present study reports that sine oculis homeobox homolog 1 (SIX1) is able to promote EMT of cervical cancer by coordinating with transforming growth factor (TGF)β-SMAD signals. The expression of SIX1 was negatively correlated with the expression of the epithelial marker E-cadherin in two independent groups of cervical cancer specimens. SIX1 could promote the transition of mesenchymal phenotype in the presence of active TGFβ signals

Indexed as

cervical cancerEMTmetastasisSIX1TGFβ

Identifiers

PMID27446426
PMCPMC4950046
OpenAlexW2463587629

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.